Skip to main content
. 2024 Sep 23;38(12):2727–2730. doi: 10.1038/s41375-024-02374-9

Fig. 2. Overall survival of patients with myeloid neoplasm based on presence or lack of ZRSR2 mutation and other co-mutations.

Fig. 2

A Overall survival for 164 ZRSR2m MN patients (with dotted red line showing median OS). B OS of ZRSR2m vs ZRSRwt in MDS patients. C OS according to the presence of an isolated TET2 co-mutation in ZRSR2m MN patients.